Altogether, our data reveal that a syntenin‐deficient environment may ultimately lead to the activation of EEF1A2/AKT/RPS6 molecular pathways in AML cells, stimulating protein synthesis and enhancing cell survival, advantages educating the leukemia to become more aggressive. The gene discussed is AKT1; the disease is acute myeloid leukemia.